Literature DB >> 23887212

Pathophysiology of traumatic brain injury.

Ayman G Mustafa1, Othaman A Alshboul.   

Abstract

Traumatic brain injury (TBI) is considered an epidemic that continues to compromise the welfare of humankind. Despite the extensive efforts invested in countering this clinical health problem, current clinical science and technology still fall short of providing a pharmacological cure for TBI rendering tens of thousands of TBI patients vulnerable to its detrimental sequelae. Over the past 30 years, the understanding of the pathophysiological mechanisms of TBI indicates that the pathology of TBI is biphasic. It comprises 2 injuries; the primary and the secondary injuries. The primary injury occurs simultaneously with the impact that caused the injury, which explains why this injury is not amenable to acute intervention. Whereas the secondary injury is a composite of interwoven pathophysiological responses that commence after the initial trauma leading to delayed, non-mechanical impairment of neuronal structure and function. In this review, we aim to highlight the main pathophysiological mechanisms that take place in the primary and secondary phases of traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887212

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  28 in total

1.  Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.

Authors:  George P Liao; Matthew T Harting; Robert A Hetz; Peter A Walker; Shinil K Shah; Christopher J Corkins; Travis G Hughes; Fernando Jimenez; Steven C Kosmach; Mary-Clare Day; KuoJen Tsao; Dean A Lee; Laura L Worth; James E Baumgartner; Charles S Cox
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

2.  Orally Administered Cinnamon Extract Attenuates Cognitive and Neuronal Deficits Following Traumatic Brain Injury.

Authors:  Doaa Qubty; Vardit Rubovitch; Tali Benromano; Michael Ovadia; Chaim G Pick
Journal:  J Mol Neurosci       Date:  2020-09-08       Impact factor: 3.444

3.  Guanosine Protects Against Traumatic Brain Injury-Induced Functional Impairments and Neuronal Loss by Modulating Excitotoxicity, Mitochondrial Dysfunction, and Inflammation.

Authors:  Rogério da Rosa Gerbatin; Gustavo Cassol; Fernando Dobrachinski; Ana Paula O Ferreira; Caroline B Quines; Iuri D Della Pace; Guilherme L Busanello; Jessié M Gutierres; Cristina W Nogueira; Mauro S Oliveira; Félix A Soares; Vera M Morsch; Michele R Fighera; Luiz Fernando F Royes
Journal:  Mol Neurobiol       Date:  2016-11-09       Impact factor: 5.590

4.  Bazedoxifene protects cerebral autoregulation after traumatic brain injury and attenuates impairments in blood-brain barrier damage: involvement of anti-inflammatory pathways by blocking MAPK signaling.

Authors:  Yu-Long Lan; Xun Wang; Yu-Jie Zou; Jin-Shan Xing; Jia-Cheng Lou; Shuang Zou; Bin-Bin Ma; Yan Ding; Bo Zhang
Journal:  Inflamm Res       Date:  2019-01-31       Impact factor: 4.575

5.  Ouabain improves functional recovery following traumatic brain injury.

Authors:  Moran Dvela-Levitt; Hagit Cohen-Ben Ami; Haim Rosen; Esther Shohami; David Lichtstein
Journal:  J Neurotrauma       Date:  2014-10-10       Impact factor: 5.269

Review 6.  Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury.

Authors:  Mohammad Khaksari; Zahra Soltani; Nader Shahrokhi
Journal:  Transl Stroke Res       Date:  2017-11-19       Impact factor: 6.829

7.  Traumatic Brain Injury Imaging in the Second Near-Infrared Window with a Molecular Fluorophore.

Authors:  Xiao-Dong Zhang; Huasen Wang; Alexander L Antaris; Lulin Li; Shuo Diao; Rui Ma; Andy Nguyen; Guosong Hong; Zhuoran Ma; Joy Wang; Shoujun Zhu; Joseph M Castellano; Tony Wyss-Coray; Yongye Liang; Jian Luo; Hongjie Dai
Journal:  Adv Mater       Date:  2016-06-02       Impact factor: 30.849

8.  Tetramethylpyrazine reduces blood-brain barrier permeability associated with enhancement of peripheral cholinergic anti-inflammatory effects for treating traumatic brain injury.

Authors:  Aimin Wang; Guangbin Zhu; Ping Qian; Tao Zhu
Journal:  Exp Ther Med       Date:  2017-07-10       Impact factor: 2.447

Review 9.  Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?

Authors:  Fatemeh Dehghanian; Zahra Soltani; Mohammad Khaksari
Journal:  J Mol Neurosci       Date:  2020-01-02       Impact factor: 3.444

10.  Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.

Authors:  Hadar Arien-Zakay; Galit Gincberg; Arnon Nagler; Gadi Cohen; Sigal Liraz-Zaltsman; Victoria Trembovler; Alexander G Alexandrovich; Ilan Matok; Hanan Galski; Uriel Elchalal; Peter I Lelkes; Philip Lazarovici; Esther Shohami
Journal:  J Neurotrauma       Date:  2014-07-14       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.